Melissa L. Johnson

566 posts

Melissa L. Johnson banner
Melissa L. Johnson

Melissa L. Johnson

@MLJohnsonMD2

Medical oncologist whose focus is drug development for lung cancer patients being treated in the community.

Sarah Cannon Research Institute Katılım Ekim 2015
630 Takip Edilen3.1K Takipçiler
Melissa L. Johnson retweetledi
ASCO
ASCO@ASCO·
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more: brnw.ch/21wQwer
ASCO tweet media
English
3
10
65
33.1K
Melissa L. Johnson retweetledi
SCRI Oncology Partners
SCRI Oncology Partners@SCRIOncology·
❤️ Celebrating love & strength at SCRI Oncology Partners! ❤️ Today, we honor our patients’ resilience, our staff’s dedication, & the love that keeps us all going. Hope, care, & kindness make a difference—today and every day. #ValentinesDay #SCRIOncologyPartners
SCRI Oncology Partners tweet media
English
0
2
7
913
Melissa L. Johnson retweetledi
Elisabeth Potter MD
Elisabeth Potter MD@EPotterMD·
On January 7th, 2025 I shared a video, after I was asked to call UnitedHealthcare from the operating room to answer administrative questions about the patient who was having surgery to treat breast cancer. Despite my efforts, they denied her stay. UnitedHealthcare didn’t stop at calling me during surgery. Now, they’ve sent me a legal threat—and even worse? They ended up denying my cancer patient’s hospital stay. Exactly what I was afraid would happen. Staying overnight after major surgery isn’t optional—it’s medically necessary. But UnitedHealthcare decided they know better than the doctors caring for the patient. When they called me while I was operating, I knew that if I didn’t step out and respond immediately, they might deny her stay—leaving her with a massive bill. So, with another surgeon in the OR, I scrubbed out and called them back. But after all of that? They denied her stay anyway. And instead of fixing their broken system, they sent me a legal threat for speaking out. I’m sharing their response in full, letting their words speak for themselves. Let me be clear: I stand by everything I said. I told the truth. I was honest about what’s happening in our healthcare system. And I will not be silenced by legal threats when it comes to advocating for my patients and my ability to care for them. Denying an overnight stay that a doctor orders is dangerous. The doctor caring for the patient should be able to make these decisions without delay, pressure, or harassment. If I don’t speak up, I lose—my integrity, my voice, and the opportunity to make a difference. And while it’s intimidating to receive a letter like this from a company as powerful as UnitedHealthcare, I know where I stand. I am a woman taking care of women affected by breast cancer. I do this work with all of my heart, and I will continue to speak up for my patients—because they deserve better. I ask you to follow along, share this story, and have these conversations in your own communities. I know I’m not the only one dealing with this, and real change will take all of us telling our stories and standing up for what’s right. I’m here for it. Are you?
English
748
8K
25.1K
1.3M
Melissa L. Johnson retweetledi
Clay Stauffer
Clay Stauffer@PreacherClay·
This…
Clay Stauffer tweet media
English
0
1
10
789
Melissa L. Johnson retweetledi
Clay Stauffer
Clay Stauffer@PreacherClay·
Goal post in the Cumberland!!
English
1
3
20
2.1K
Melissa L. Johnson retweetledi
RobynsResistance247💙🇺🇸
RobynsResistance247💙🇺🇸@RobynEvansinCal·
@DirtRoadPickup I agree he is pure evil 👿 your wife is a very smart woman. Smart women will help lead this Country out of chaos, hate & division to keep our Democracy alive & well.
English
65
140
1.6K
63.3K
Melissa L. Johnson retweetledi
JessicaJLinMD
JessicaJLinMD@JessicaJLinMD·
We are pleased to share this article out today in @CD_AACR on the preclinical development and proof-of-concept clinical activity of NVL-655 ✅4th-generation, #ALK-selective TKI ✅CNS-penetrant ✅Broad coverage of ALK fusions and mutations, including lorlatinib-refractory compound mutations 🔥Fills an important unmet need for pts with ALK+ lung cancer and other solid tumors 📢Tune in for updated prelim efficacy&safety data from the global ongoing phase I/II study (ALKOVE-1) of NVL-655 to be presented TOMORROW at #ESMO2024! @ALKPositiveinc @ALKpositiveINT @MGHCancerCenter @MassGeneralNews @alexdrilon @MSKCancerCenter @BenjaminBesseMD @MLJohnsonMD2 @DRCamidge @jii_bum_lee @ViolaWZhu aacrjournals.org/cancerdiscover…
JessicaJLinMD tweet media
English
9
36
114
9.9K
Melissa L. Johnson retweetledi
Mary Jo Fidler
Mary Jo Fidler@maryjofidlerMD·
WCLC off to a great start! Dr Rudin presents IDxd in extensive stage small cell. High disease control with higher dose, predominantly GI tox #wclc24
Mary Jo Fidler tweet mediaMary Jo Fidler tweet media
English
0
5
12
1.2K
Melissa L. Johnson retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
Looking forward to #WCLC24 - join us for lunch on Monday September 9th, 12:15pm, Ballroom 20A (Upper Level) - where we'll discuss updates in ADCs for lung cancer in this @PeerView #CME with Drs. @MLJohnsonMD2 @dplanchard and me! Hope to see you there!
Stephen V Liu, MD tweet media
English
1
9
43
4.7K
Melissa L. Johnson
Melissa L. Johnson@MLJohnsonMD2·
Stuck @Schiphol airport going on 48 hours. Delayed, cancelled, delayed, cancelled @AmericanAir. So much for being #platinumexecutive …I see how little that actually means to AA. I blame CEO Robert Isom. Inept operations starts with poor leadership.
English
3
0
3
1.4K